arista
28-12-2025, 09:39 AM
[A new twice-yearly asthma injection,
Depomycin (brand name Exdensur),
has been approved by the UK and US regulators
for severe asthma,
But its initial availability will likely be
through private healthcare
with a high price tag.
The cost has led to concerns about accessibility,
at least in the short term]
Was on SkyNews Newspaper Review 8:45 AM
Twice a Year will help.
Depomycin (brand name Exdensur),
has been approved by the UK and US regulators
for severe asthma,
But its initial availability will likely be
through private healthcare
with a high price tag.
The cost has led to concerns about accessibility,
at least in the short term]
Was on SkyNews Newspaper Review 8:45 AM
Twice a Year will help.